Glenmark Life Sciences IPO GMP - Latest Grey Market Premium, Grey Market Premium Today & review
Know All About Glenmark Life Sciences IPO as on Today - Glenmark Life Sciences IPO GMP (Glenmark Life Sciences IPO Gray Market Premium), Kostak rates, and Subject to Sauda rates, Glenmark Life Sciences IPO Review. We will update Gray Market Premium everyday. Glenmark Life Sciences IPO will start from 27th July 2021, all information about Glenmark Life Sciences IPO is given below.
Glenmark Life Sciences IPO (Initial Public Offering) will open for subscription on 27th July 2021 and remain open for bidding till 29th July 2021. Incorporated in 2011, they are the leading manufacturer of Active Pharmaceutical Ingredients (APIS). The IPO price band of Glenmark Life Sciences has been fixed from ₹695 to ₹720. The company wants to raise Rs 1514 crore through Initial Public Offering (IPO). Where Rs 1060 crore will be from fresh issue and the rest will be under OFS (Offer for Sale). In this IPO, shares worth Rs 454 crore will be sold through an offer for sale. The Glenmark Life Sciences IPO will be listed on NSE and BSE on 06 august. Glenmark Life Sciences is one of the largest APIs-making companies.
👉🏻 What is Glenmark Life Sciences IPO GMP Today?
The Glenmark Life Sciences IPO GMP( grey market premium) is ₹90.
👉🏻 What is Glenmark Life Sciences IPO Kostak Rates Today?
The Glenmark Life Sciences IPO kostak rate is ₹0.
👉🏻 Glenmark Life Sciences IPO Expected Returns (in %)?
The Glenmark Life Sciences expected return is aprox 10% to 15%.
Glenmark Life Sciences GMP (Grey Market Premium)
DATE | GMP | COSTAK |
---|---|---|
15 July | ₹0 | ₹0 |
16 July | ₹0 | ₹0 |
17 July | ₹0 | ₹0 |
18 July | ₹0 | ₹0 |
19 July | ₹0 | ₹0 |
20 July | ₹0 | ₹0 |
21 July | ₹300 | ₹600 |
22 July | ₹250 | ₹350 |
23 July | ₹200 | ₹300 |
24 July | ₹200 | ₹300 |
25 July | ₹200 | ₹300 |
26 July | ₹150 | ₹200 |
27 July | ₹120 | ₹350 |
28 July | ₹140 | ₹300 |
29 July | ₹150 | ₹300 |
30 July | ₹150 | ₹300 |
31 July | ₹150 | ₹300 |
01 August | ₹150 | ₹300 |
02 August | ₹150 | ₹300 |
03 August | ₹95 | ₹300 |
04 August | ₹85 | ₹0 |
05 August | ₹90 | ₹0 |
06 August | ₹90 | ₹0 |
Glenmark Life Sciences IPO Date and Price Band Details
IPO Open | 27th July 2021 |
IPO Close | 29th July 2021 |
Listing Date | 06 August 2021 |
Listing On | NSE & BSE |
IPO Size | Approx ₹1514 Crores |
Fresh Issue | Approx ₹1060 Crores |
Offer For Sale | Approx ₹454 Crores |
Price Band | ₹695 to ₹720 Per Share |
Face Value | ₹2 Per Equity Share |
PE | -- |
Equity | Shares |
Retail Portion | 35% |
Glenmark Life Sciences IPO Market Lot & Size
Minimum Lot | 01 |
Minimum Lot Size | 20 Shares |
Minimum Amount | ₹14,400 |
Maximum Lot | 13 |
Maximum Lot Size | 260Shares |
Maximum Amount | ₹1,87,200 |
Glenmark Life Sciences IPO Allotment & Listing Date
Basis of Allotment | 03 August 2021 |
Refund Date | 04 August 2021 |
Credit to Demat Account | 05 August 2021 |
Listing Date | 06 August 2021 |
Purpose of the offer
- Payment of outstanding purchase consideration to the promoter for spin-off of API business from the promoter in the company.
- Funding of capital expenditure requirements.
- General corporate purposes.
Glenmark Life Sciences IPO Review
! Note:- Rated by Happiest Post
Glenmark Life Sciences Ipo Review
Review For Listing Gain
Review For Short Term
Review For Long Term
Strength
- Creating APIs is Glenmark's expertise.The company is the market leader in API manufacturing.
- It's APIs are exported not only to India but also to Latin America, North America, Europe, Japan and many other countries. The company gets global recognition due to its exports to many countries.
- Not only this, he also has a good relationship with the global company. Glenmark has been able to retain 69% of its customers for the last 3 years.
weakness
- Now we talk about the risk of the company, then the biggest risk factor of the company is that most of their revenue comes from API business. That is, their revenue generation mostly comes from API sales. About 85-90% of their revenue comes from API sales.
- If it is to make them a good quality API, they also need good quality raw material. If they get raw material of low flame quality or late, it will affect their manufacturing which will affect their sales. And if there is no sales then their revenue will also be less. It is mainly dependent on India (60%) and China (40%) for raw materials.
- Dependency of sale of product to limited customers.
Glenmark Life Sciences Finacials
Year | Revenue from Operations | PAT | EBITDA | EBITDA MARGIN |
---|---|---|---|---|
2019 | ₹1405 | - | ₹331.6 | ₹27.60% |
2020 | ₹1537 | ₹195.5 | ₹429.8 | ₹30.59% |
2021 | ₹1418 | ₹313 | ₹483.9 | ₹31.48% |
Revenue from API Business
Year | Revenue from APIs Business |
---|---|
2019 | 89.87% |
2020 | 84.16% |
2021 | 90.63% |
FAQs About Glenmark Life Sciences Ipo
What is the Glenmark Life Sciences IPO opening date?
- Glenmark Life Sciences IPO opening date is 27 July.
What is Glenmark Life Sciences IPO GMP Today?
- Glenmark Life Sciences IPO GMP is ₹90 as on today.
How much is Glenmark Life Sciences IPO Kostak Rate Today?
- Glenmark Life Sciences IPO Kostak Rate is ₹0 as on today.
What is the Glenmark Life Sciences IPO Closing date?
- Glenmark Life Sciences IPO Closing date is 29 July.
What is the Glenmark Life Sciences IPO listing date?
- Glenmark Life Sciences IPO listing date is 06 August.
What is Glenmark Life Sciences IPO Subject to Sauda Today?
- Glenmark Life Sciences IPO Subject to Sauda is ₹-- as on today.
What is Glenmark Life Sciences IPO Expected Returns after Listing?
- Glenmark Life Sciences IPO Expected Returns is 10-15%.
For other important information related to the stock market and Grey Market Premium, you can click on the links given below.
We hope you like this article very much. Feedback is kindly invited. Tnanks For visiting. please comment.
1 Comments
Great Information.
ReplyDeleteWe are waiting for your comments. 💙